The table below shows Caribou Biosciences, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$11.16M
$9.99M
$34.48M
$13.85M
$9.60M
$12.36M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$109.44M
$130.15M
$112.08M
$82.23M
$52.26M
$34.42M
SG&A
$37.91M
CRBU annual revenue (10-K history)
Caribou Biosciences, Inc. reported annual revenue of $11.16M for fiscal year 2025. That is up 11.7% from $9.99M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $5.79M (FY 2019) to $11.16M. Figures come from the company's audited annual reports as filed with the SEC.